These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30467994)

  • 61. Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results.
    Kervinen K; Niemelä M; Romppanen H; Erglis A; Kumsars I; Maeng M; Holm NR; Lassen JF; Gunnes P; Stavnes S; Jensen JS; Galløe A; Narbute I; Sondore D; Christiansen EH; Ravkilde J; Steigen TK; Mannsverk J; Thayssen P; Hansen KN; Helqvist S; Vikman S; Wiseth R; Aarøe J; Jokelainen J; Thuesen L;
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1160-5. PubMed ID: 24262616
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Procedural and 1-year outcomes following large vessel coronary artery perforation treated by covered stents implantation: Multicentre CRACK registry.
    Wańha W; Januszek R; Kołodziejczak M; Kuźma Ł; Tajstra M; Figatowski T; Smolarek-Nicpoń M; Gruz-Kwapisz M; Tomasiewicz B; Bartuś J; Łoś A; Jagielak D; Roleder T; Włodarczak A; Kulczycki J; Kowalewski M; Hudziak D; Stachowiak P; Gorący J; Sierakowska K; Reczuch K; Jaguszewski M; Dobrzycki S; Smolka G; Bartuś S; Ochała A; Gąsior M; Wojakowski W
    PLoS One; 2021; 16(5):e0249698. PubMed ID: 33979357
    [TBL] [Abstract][Full Text] [Related]  

  • 63. First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent: Angiographic, IVUS, OCT, and Clinical Outcomes From the RevElution Study.
    Worthley SG; Abizaid A; Kirtane AJ; Simon DI; Windecker S; Brar S; Meredith IT; Shetty S; Sinhal A; Almonacid AP; Chamié D; Maehara A; Stone GW;
    JACC Cardiovasc Interv; 2017 Jan; 10(2):147-156. PubMed ID: 28104208
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Risk Factors and Long-Term Clinical Outcomes of Second-Generation Drug-Eluting Stent Thrombosis.
    Kuramitsu S; Ohya M; Shinozaki T; Otake H; Horie K; Kawamoto H; Yamanaka F; Natsuaki M; Shiomi H; Nakazawa G; Ando K; Kadota K; Saito S; Kimura T
    Circ Cardiovasc Interv; 2019 Jun; 12(6):e007822. PubMed ID: 31177822
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long-term clinical outcome after implantation of the self-expandable STENTYS stent in a large, multicenter cohort.
    Gaede L; Liebetrau C; Dörr O; Blumenstein J; Elsässer A; Hamm CW; Möllmann H; Schlundt C; Nef HM; Achenbach S
    Coron Artery Dis; 2017 Nov; 28(7):588-596. PubMed ID: 28704242
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Incidence, predictors, and clinical outcomes of early stent thrombosis in acute myocardial infarction patients treated with primary percutaneous coronary angioplasty (insights from the University of Ottawa Heart Institute STEMI registry).
    Singh K; Rashid M; So DY; Glover CA; Froeschl M; Hibbert B; Chong AY; Dick A; Labinaz M; Le May M
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):842-848. PubMed ID: 28733995
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Coronary artery perforation complicating percutaneous coronary intervention.
    Mirza AJ; Taha AY; Aldoori JS; Hawas JM; Hassan KW
    Asian Cardiovasc Thorac Ann; 2018 Feb; 26(2):101-106. PubMed ID: 29338301
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Outcome of everolimus eluting bioabsorbable vascular scaffold (BVS) compared to non BVS drug eluting stent in the management of ST-segment elevation myocardial infarction (STEMI) - A comparative study.
    Chakraborty R; Patra S; Banerjee S; Pande A; Khan A; Mandol PC; Ghosh D; De SK; Das SS; Nag R
    Cardiovasc Revasc Med; 2016; 17(3):151-4. PubMed ID: 26905052
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The efficacy and safety of PRO-kinetic metal alloy stent in hospitalized patients with acute ST-elevation myocardial infarction (The PROMETHEUS Study).
    Lim SY; Park HW; Chung WY; Kim SY; Kim KS; Bae JW; Youn TJ;
    J Invasive Cardiol; 2012 Jun; 24(6):270-3. PubMed ID: 22684380
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
    Holmvang L; Kelbæk H; Kaltoft A; Thuesen L; Lassen JF; Clemmensen P; Kløvgaard L; Engstrøm T; Bøtker HE; Saunamäki K; Krusell LR; Jørgensen E; Tilsted HH; Christiansen EH; Ravkilde J; Køber L; Kofoed KF; Terkelsen CJ; Helqvist S
    JACC Cardiovasc Interv; 2013 Jun; 6(6):548-53. PubMed ID: 23683734
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Polymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions: 4- and 12-Month Angiographic Follow-Up and Final 5-Year Clinical Outcomes of the Prospective, Multicenter BioFreedom FIM Clinical Trial.
    Costa RA; Abizaid A; Mehran R; Schofer J; Schuler GC; Hauptmann KE; Magalhães MA; Parise H; Grube E;
    JACC Cardiovasc Interv; 2016 Jan; 9(1):51-64. PubMed ID: 26762911
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The EXTREME registry: titanium-nitride-oxide coated stents in small coronary arteries.
    Valdesuso R; Karjalainen P; García J; Díaz J; Portales JF; Masotti M; Picó F; Serra A; Burgos JM; Insa L; Mauri F; Collado JR; Nammas W
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):281-7. PubMed ID: 20665878
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial.
    Harada Y; Colleran R; Kufner S; Giacoppo D; Rheude T; Michel J; Cassese S; Ibrahim T; Laugwitz KL; Kastrati A; Byrne RA;
    Cardiovasc Diabetol; 2016 Sep; 15(1):124. PubMed ID: 27586678
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial).
    Maeng M; Baranauskas A; Christiansen EH; Kaltoft A; Holm NR; Krusell LR; Ravkilde J; Tilsted HH; Thayssen P; Jensen LO
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1161-7. PubMed ID: 25640050
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization: From the WIN-DES Collaborative Patient-Level Pooled Analysis.
    Giustino G; Baber U; Aquino M; Sartori S; Stone GW; Leon MB; Genereux P; Dangas GD; Chandrasekhar J; Kimura T; Salianski O; Stefanini GG; Steg PG; Windecker S; Wijns W; Serruys PW; Valgimigli M; Morice MC; Camenzind E; Weisz G; Smits PC; Kandzari DE; Galatius S; Von Birgelen C; Saporito R; Jeger RV; Mikhail GW; Itchhaporia D; Mehta L; Ortega R; Kim HS; Kastrati A; Chieffo A; Mehran R
    JACC Cardiovasc Interv; 2016 Apr; 9(7):674-84. PubMed ID: 27056305
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Safety and Effectiveness of Everolimus-Eluting Stents in Chronic Total Coronary Occlusion Revascularization: Results From the EXPERT CTO Multicenter Trial (Evaluation of the XIENCE Coronary Stent, Performance, and Technique in Chronic Total Occlusions).
    Kandzari DE; Kini AS; Karmpaliotis D; Moses JW; Tummala PE; Grantham JA; Orr C; Lombardi W; Nicholson WJ; Lembo NJ; Popma JJ; Wang J; Larracas C; Rutledge DR
    JACC Cardiovasc Interv; 2015 May; 8(6):761-769. PubMed ID: 25912400
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sirolimus-eluting versus paclitaxel-eluting stents in diabetic and non-diabetic patients within sirolimus-eluting stent restenosis: results from the ISAR-DESIRE 2 trial.
    Kufner S; Byrne RA; de Waha A; Schulz S; Joner M; Laugwitz KL; Kastrati A;
    Cardiovasc Revasc Med; 2014 Mar; 15(2):69-75. PubMed ID: 24684757
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.